3[1]Bingley P J,Bonifacio E,Williams A J K,et al.Prediction of IDDM in the general population strategies based on combinations of autoantibody markers[J].Diabe tes,1997,46(11):1701-1710.
4[2]Bingley P J,Christie M R,Bonifacio E,et al.Combined analysis of autoa ntibodies improves prediction of IDDM in islet cell antibodypositive relatives[J].Diabetes,1994,43（8）:1304-1310.
5[3]Hagopian W A,Sanjeevi C B,Kockum I,et al.Glutamate decarboxylase,insulin and islet cell antibodies and HLA typing to detect diabetes in a general populationbased study of Swedish children[J].J Clin Invest,1995,95（４）:1505-1511.
6Haffner SM, Miettinen H, Stern MP. The homeostasis model in the San Antonio heart study. Diabetes Care, 1997,20:1087-1092.
7Phillips DI, Clark PM, Hales CN, et al. Understanding oral glucose tolerance: comparison of glucose of insulin resistance and secretion. Diabet Med , 1994,11:286-292.
8Defronzo RA, Ferrannini E, Simensen DC. Fasting hyperglycemia in non-insulin-dependent diabetes mellitus, contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism, 1989,38:387-395.
9Pimenta W, Korytkowski M, Mitrakou A, et al. Pancreatic β-cell dysfuction as the primary genetic lesion in NIDDM: evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative. JAMA, 1995,273:1855-1861.
10Melchionda N, Forlani G, Marchesini G, et al. WHO and ADA criteria for the diagnosis of diabetes mellitus in relation to body mass index. Insulin sensitivity and secretion in resulting subcategories of glucose tolerance. Int J Obes Relat Metab Disord, 200
